Developer of therapeutic strategies for thrombosis raises millions in Series A round 24-Feb-2022 By Jane Byrne TargED Biopharmaceuticals, a spin-off from the University Medical Center Utrecht that is developing therapies to improve treatment of thrombosis, has raised Series A financing of €39m (US$44.1m)
Blackstone launches cardio-focused biopharma with Novartis 28-Feb-2019 By Maggie Lynch Blackstone launches Anthos Therapeutics, with the help of Novartis, to develop targeted therapies for cardiovascular disease.